Radiation therapy can modulate the tumor microenvironment, enhancing the expression of molecules such as PD-L1, thus providing a rationale for the subsequent introduction of immunotherapeutic agents like PD-1/PD-L1 inhibitors. Here, PDCD1 is linked to neoplasm.